1 RORγt-expressing Tregs form a specialized subset of intestinal CD4 + Foxp3 + cells which is 2 essential to maintain gut homeostasis and tolerance to commensal microbiota. Recently, c-3 Maf emerged as a critical factor in the regulation of RORγt expression in Tregs. However, 4 save c-Maf, the signaling pathways involved in the differentiation of RORγt + Tregs and their 5 possible interplay with c-Maf in this process are largely unknown. We show that RORγt + Treg 6 development strongly relies on signals derived from a complex microbiota, as well as IL-7 6/STAT3-and TGF-β-derived signals, although deficiency in either signaling pathway barely 8 affects c-Maf expression. Ectopic expression of c-Maf did not rescue RORγt expression in 9 STAT3-deficient Tregs, indicating additional effectors downstream of STAT3. Moreover, we 10 show that an inflammatory IFN-γ/STAT1 signaling pathway opposes RORγt + Treg 11 differentiation in a c-Maf independent fashion. 12 These data thus argue for a complex integrative signaling network that finely tunes RORγt 13 expression in Tregs. The finding that type 1 inflammation impedes RORγt + Treg development 14 even in the presence of an active IL-6/STAT3 pathway further suggests a dominant negative 15 effect of STAT1 over STAT3 in this process. 16 immunity, thus revealing a double-edged function of this Treg subset in immune homeostasis 1 (Downs-Canner et al., 2017). However, despite their importance in physiological and 2 pathological immune responses, the factors driving RORγt + Treg differentiation are still 3 incompletely defined. 4 The transcription factor c-Maf, belonging to the AP-1 family of basic region/leucine zipper 5 transcription factors, is expressed by distinct CD4 + T cell subsets, including Th17, Th2, Tfh 6 and Tr1 cells, and is thought to regulate the expression of IL-10, IL-4, and IL-21 through the STAT3 Contribute to T Cell Pathogenicity and Homeostasis. Immunity 32:605-615. . 2013. Commensal 6 microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 7 CD4+ T cells.
intestinal immunopathology in different colitis models (Lochner, 2011; Ohnmacht et al., 16 2015; Sefik et al., 2015; Yang et al., 2015) and to mediate immunological tolerance to the gut 17 pathobiont Helicobacter hepaticus (Xu et al., 2018) . A recent study showed that thymic-18 derived Tregs also expressed RORγt in lymph nodes following immunization and were able to 19 protect mice from Th17 cell-mediated CNS inflammation (Kim et al., 2017) . Although RORγt 20 (ranging from 20% to 85%) expressed c-Maf in all the examined organs, with a notable 8 exception for the thymus (Figure 1A, B ). In the intestine, both RORγt + and RORγt -Treg 9 subsets expressed c-Maf, although expression levels were higher in the RORγt + compartment 10 ( Figure 1A Figure S2 ). c-Maf deficiency did not affect the percentage of intestinal GATA3 + Tregs 20 ( Figure 1G , J), further indicating that c-Maf is specifically required for Tregs to acquire 21
RORγt expression. 22
Strikingly, FACS analysis also revealed that a large fraction of c-Maf + Tregs do not express 23
RORγt. This was observed in all the examined organs and was most evident in the small 24 intestine lamina propria, where two-thirds of the c-Maf + Tregs lacked RORγt expression 25 ( Figure 1A ). c-Maf expression was mainly found among effector Tregs, which express high 1 levels of ICOS and CD44 ( Figure S3 ). In contrast to RORγt + Tregs, which were mostly of 2 peripheral origin, c-Maf + Tregs were found both in Nrp1 + and Nrp1 -Tregs, suggesting that c-3 Maf + Tregs can be of thymic or peripheral origin (Figure 2A, B) . Thymic c-Maf + Tregs were 4 enriched in the spleen whereas their peripheral counterparts were enriched in mesenteric 5 lymph nodes and formed the majority of intestinal Tregs ( Figure 2C ). Altogether, these data 6 indicate that c-Maf + Tregs can be divided into distinct compartments and that only a fraction 7 of c-Maf + Tregs co-express RORγt. the Rorc locus, albeit at distinct preferential sites ( Figure 5K ). 2
To determine whether the role of STAT3 in promoting RORγt induction solely relies on c-3 Maf, we restored c-Maf expression in STAT3-deficient iTreg17 cells. WT and c-Maf KO 4 CD4 T cells were infected with a control-GFP or a c-Maf-GFP encoding retrovirus. As shown 5 in Figure 6A , infection with the c-Maf-GFP retrovirus restored optimal levels of c-Maf in 6 both c-Maf KO and STAT3 KO Tregs. Although the c-Maf encoded RV did restore RORγt 7 expression in c-Maf-deficient Tregs, it was unable to do so in the STAT3 KO Tregs (Figure  8 6B). Collectively, these data indicate that in Tregs, an additional STAT3-driven but cMaf-9 independent pathway is required to promote optimal RORγt. 10
11

A pro-Th1 inflammatory environment dampens RORγt expression in Tregs 12
While IL-6 promoted RORγt expression in wild type iTregs, it surprising led to a marked 13 reduction of this transcription factor in STAT3-deficient iTregs ( This reciprocal exclusion was also reflected among Tregs, as T-bet and RORγt were 7 expressed in distinct Treg cell subsets in the infected mice ( Figure 7C ). 8
We next wished to evaluate the effect of Th1-promoting signals on RORγt expression by 9
Tregs, Addition of IFN-γ to the iTreg17 differentiation media led to the selective 10 accumulation of the phosphorylated form of STAT1, without affecting phospho-STAT3 11 accumulation ( Figure S8 ). IFN-γ increased the expression of Tbet, with a concomitant 12 reduction in RORγt + expression ( Figure 7D profile (Hirahara et al., 2015) . Yet, in the absence of STAT3, and despite a global reduction in 24 STAT1 chromatin binding, some preferential STAT1 binding sites were conserved in a group 25 of IL-6 downregulated genes. With this in mind we hypothesized a negative influence of 1 STAT1 on RORγt expression by Tregs. Indeed, STAT3-deficient T cells showed increased 2 STAT1 phosphorylation in response to IL-6, compatible with a switch from STAT3 to 3 STAT1 signaling in these cells. We further showed that IFN-γ-driven activation of STAT1 4 opposed RORγt expression in Tregs, without affecting Foxp3 and c-Maf expression or 5 STAT3 phosphorylation. Naïve STAT1 KO mice did not show altered proportions of 6
intestinal RORγt + Tregs (data not shown), but that could be explained by the lack of 7 inflammatory Th1 components at steady state. Indeed, in wild type mice infected with the In the latter group, overactive STAT1 appears to limit STAT3-driven antifungal responses 24 (Casanova et al., 2012). 25
Further work is required to decipher whether STAT1 interacts with STAT3 or exerts an 1 independent negative role on RORγt + Treg cell fate. As T-bet is induced in Tregs that develop 2 during Toxoplasma infection or in response to IFN-γ, we can also envision that STAT1 3 signaling inhibits RORγt expression through T-bet blocking of Runx1-mediated 4 transactivation of Rorc, as previously reported for the Th1/Th17 lineage specification 5 (Lazarevic et al., 2011) . Regardless of the molecular mechanism, the observation that IFN-6 γ /STAT1 signaling pathway negatively regulates RORγt, even in the presence of an active IL-7 6/STAT3 pathway, suggests a dominant negative effect of STAT1 over STAT3 in these 8 experimental conditions. 9
The antagonism between STAT1 and STAT3 seems to be cell type-specific or specific to a 10 certain gene locus, as a cooperation between STAT1 and STAT3 downstream of IL-6 has 11 been described for optimal Bcl6 induction and Tfh differentiation in response to viral BB515, CD44-PECy7, CD4-A700, CD4-PB, CD62L-A700, GATA3-PE, RORγt-PECF594, 24 STAT1 (pY701)-A488, STAT3 (pY705)-A647, streptavidin-PECy7. 25 1 transcription factor staining, cells were stained for surface markers, followed by fixation and 2 permeabilization before nuclear factor staining according to the manufacturer's protocol 3 (FOXP3 staining buffer set from eBioscience). For phosphorylation staining, cells were fixed 4 with formaldehyde and permeabilized with methanol before staining. Flow cytometric 5 analysis was performed on a Canto II (BD Biosciences) or CytoFLEX (Beckman Coulter) and 6 analyzed using FlowJo software (Tree Star). 7
Isolation of lymphocytes. After removal of Peyer's patches and mesenteric fat, intestinal 8
tissues were washed in HBSS 3% FCS and PBS, cut in small sections and incubated in HBSS 9 3% FCS containing 2,5mM EDTA and 72,5 µg/mL DTT for 30 min at 37°C with agitation to 10 remove epithelial cells, and then minced and dissociated in RPMI containing liberase (20 11 µg/ml, Roche) and DNase (400 µg/ml, Roche) at 37 °C for 30 min (small intestine) or 45 min 12 (colon). Leukocytes were collected after a 30% Percoll gradient (GE Healthcare). Lymph 13 nodes, thymus and spleens were mechanically disrupted in culture medium. Sigma-Aldrich; vancomycin 0,5g/L and metronidazole 1 g/L, Duchefa) were added to the 19 sweetened drinking water of mice treated with antibiotics for three to four weeks. Control 20 mice were given sweetened drinking water in parallel. 21
Toxoplasma infection. ME-49 type II T. gondii was kindly provided by Dr De Craeye 22
(Institut Scientifique de Santé Publique, Belgium) and was used for the production of tissue 23 cysts in C57BL/6 mice, which were inoculated 1-3 months previously with three cysts by 24 gavage. Animals were killed, and the brains were removed. Tissue cysts were counted and 25 mice were infected by intragastric gavage with 10 cysts. Mice were sacrificed at day 8 after 1 infection. 2 T cell culture. Naive CD4 + T cells were purified from spleen of mice with indicated 3 genotypes. CD4 + T cells were positively selected from organ cell suspensions by magnetic-4 activated cell sorting using CD4 beads (MACS, Miltenyi) according to the product protocol, 5 and then isolated as CD4 + CD44 lo CD62L hi CD25 − or CD4 + CD44 lo CD62L hi YFP − by FACS. T 6 cells were cultured at 37°C in RPMI supplemented with 5% heat-inactivated FBS (Sigma-7 Aldrich), 1% non-essential amino acids (Invitrogen), 1 mM sodium pyruvate (Invitrogen), 2 8 mM L-glutamin (Invitrogen), 500 U/mL penicillin/500 µg/ml streptomycin (Invitrogen), and 9 50 μ M β -mercaptoethanol (Sigma-Aldrich). 10
To generate iTreg cells, cells were cultured 72h in 24 or 96 well plates coated with 5µg/mL 11 anti-CD3 (BioXcell, 145-2c11) at 37°C for 72h. The culture was supplemented with anti-12 CD28 (1 µg/mL, BioXcell, 37.51) and TGF-β alone (3 ng/ml, eBioscience), TGF-β and IL-2 13 (10 ng/mL, Peprotech), or TGF-β, IL-2 and IL-6 (10 ng/mL, eBioscience) for optimal iTreg 14 cell polarization. Acetate (C2, 10 mM), propionate (C3, 0,5 mM), butyrate (C4, 0,125 mM), 15 all from Sigma-Aldrich, and IFN-γ (10 and 100 ng/mL, Peprotech) were also used and added 16 to the culture for the whole duration of the experiment. 17
Retroviral infection. Platinum-E retroviral packaging cells (T. Kitamura, University of 18
Tokyo, Tokyo, Japan) were transfected with a c-Maf encoding retroviral plasmid (pMIEG-c-19
Maf-IRES-GFP) or a control retroviral plasmid (pMIEG-IRES-GFP) to produce retrovirus-20 containing supernatants. 24 hours after activation, naïve CD4 T cells polarized in presence of 21 TGF-β, IL-2 and IL-6, as described above, were infected during a 90-minute centrifugation 22 with 1 mL retrovirus-containing supernatant and polybrene. 48 hours later, infected cells were 23 FACS-sorted based on GFP expression and were stimulated with anti-CD3 for 24 hours 24 (5µg/mL, coated) before flow cytometry staining. Statistical analysis. For unpaired data, statistical difference between groups was determined 23 by an unpaired t test when the sample size was sufficient and both groups passed the 24 normality test, and by a Mann-Whitney test for two-tailed data otherwise. Mutant and control 25 groups did not always have similar standard deviations and therefore an unpaired two-sided 1 Welch's t-test was used. For paired data, a paired t test was used. Error bars represent mean ± 2 SD. No samples were excluded from the analysis. 3 1 We especially thank Muriel Moser for her great support all along this work and stimulating 2 discussions. We also thank Caroline Abdelaziz and Véronique Dissy for animal care and for 3 technical support. This work was supported by the European Regional Development 
